Blood-based circular RNAs showed strong potential for identifying biomarker-confirmed Alzheimer’s disease and predicting progression to symptomatic disease. When combined with pTau217, the circRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results